CytomX Therapeutics, Inc. Intellectual Property Contracts & Agreements

5 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No.3 to Exclusive License Agreement effective as of April 2, 2019, by and between CytomX Therapeutics, Inc. and The Regents of the University of California
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
License Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of February 12,2016
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
MA
2018
Third Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of January 3, 2018
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Second Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of March 31, 2017
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
First Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of October 5, 2016
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018